Literature DB >> 34482759

Perceived Impact of COVID on Smoking, Vaping, Alcohol and Cannabis Use Among Youth and Youth Adults in Canada.

Michael Chaiton1,2, Jolene Dubray1, Anasua Kundu1, Robert Schwartz1.   

Abstract

Entities:  

Keywords:  COVID; addictions; adolescence

Mesh:

Year:  2021        PMID: 34482759      PMCID: PMC9065487          DOI: 10.1177/07067437211042132

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   5.321


× No keyword cloud information.

Introduction

The recent Coronavirus Disease 2019 (COVID-19) pandemic has affected the mental health of Canadians adversely[1,2] and as a result, both mental health problems and substance use among adolescents have increased.[2,3] A recent study reported that 22.6% of Canadian adults increased their alcohol consumption, including 4.8% heavy drinking, compared to their pre-pandemic alcohol consumption levels. Moreover, the frequency of both alcohol and cannabis use among adolescents has increased as well. In the United States, retail sales of alcohol and tobacco increased by 34% and 13% respectively during the early pandemic period compared to the pre-pandemic time. In addition, about half of adult cannabis users in Canada indicated that they have increased their cannabis consumption during the pandemic. There is limited evidence of changes in substance use among adolescents[2,3] and adults[4,6] in response to the COVID-19 pandemic in Canada. Exploring patterns of changes in substance use among youth and young adults is crucial and may have implications for future burden of disease.

Materials and Methods

Study Population

Youth and young adults aged 16–25 living in Canada were eligible for the survey. For this cohort, we recruited through Instagram and Facebook advertisements from August 2020 to March 2021 using a variety of recruitment messages. Almost half of each province's sample was recruited in October and November 2020. Overall, 7,745 participants completed the survey. Post-stratification weights were developed from Census data, resulting in the exclusion of 94 participants with incomplete demographic data and those who resided in Yukon, Northwest Territories and Nunavut (total n = 7,651). The analytic sample was restricted to 6,721 (87%) participants who reported using at least one of cigarettes, e-cigarettes, alcohol or cannabis during past year.

Measures

Each participant was asked “How has the COVID-19 Pandemic influenced your use of each of the following …? Increased, Decreased, Unchanged, Did not Use” for cigarettes, e-cigarettes, cannabis, and alcohol. Participants were also asked about their current use of cigarettes, e-cigarettes, cannabis, and alcohol. Demographics (age in years, sex at birth, highest level of education completed, marital status, parental status, and race) were self-reported.

Analysis

Percentages of participants who reported increases in their use of substances were calculated among participants who reported use of at least one substance. Bivariate associations between demographic characteristics of participants who reported increases in use compared to those who reported decreases/no change /did not use that substance were tested. Logistic regression was used to identify independent demographic predictors of increases in use in any substance. All analysis were conducted in Stata 14 using survey procedures and poststratification weights.

Results

The unweighted sample was 21% male, 69% under 20 years old, and 74% White (n = 7,651). The socio-demographic characteristics of the study population are presented in the Supplementary material 1. Of the 6,721 participants who reported currently using substances in their lifetime, 59% reported increasing their use of at least one substance, 55% reported increasing use of two or more substances. Comparatively, only 16% of lifetime users reported reducing their use of any substance. Current daily users of substances were most likely to report increased use. Daily cigarette smokers (81%), e-cigarettes vapers (75%), cannabis users (73%) and alcohol users (72%) reported an increase in use. Reported net increases in use overall (percent of users increasing use subtracting percent of users decreasing) during the COVID-19 pandemic were observed for cigarettes (+16%), e-cigarettes (+37%), alcohol (+19%) and cannabis (+47%). Females, those with a university degree, and people married or living with a partner were independent predictors of increased substance use (Table 1). Youth living in British Columbia and Prince Edward Island were more likely to report increased use compared to youth in Ontario. Indigenous youth were most likely to report increased use, as well as youth from South Asian and Latin American backgrounds, compared to nonvisible minority youth. Youth from Chinese and Southeast Asian backgrounds were less likely to report increased substance use.
Table 1.

Predictors of Increase in Substance Use Due to the Coronavirus Disease 2019 (COVID-19) Pandemic Among Youth and Young Adults Using at Least One Substance (n = 6,721).

CharacteristicOR (95% CI)
Age1.02
(0.93,1.12)
Sex (ref: male)0.48***
(0.36,0.64)
Education (ref: less than high school)0.60***
(0.49,0.73)
Race (ref: White)
 Black0.75
(0.35,1.61)
 Chinese0.17***
(0.07,0.38)
 Filipino0.45*
(0.22,0.92)
 Indigenous3.16**
(1.39,7.21)
 Japanese0.34*
(0.12,0.99)
 Korean1.55
(0.75,3.21)
 Latin-Central-South American2.90**
(1.49,5.64)
 Southeast Asian0.06***
(0.02,0.17)
 South Asian3.10**
(1.56,6.18)
 West Asian0.88
(0.45,1.73)
 Another Background1.5
(0.72,3.15)
Married (ref: Single)5.00***
(3.54,7.06)
Parent/legal guardian of children (ref. no children)1.37
(0.57,3.31)
Province (ref. Ontario)
 Alberta1.01
(0.54,1.90)
 British Columbia3.34**
(1.34,8.34)
 Manitoba0.71
(0.38,1.31)
 New Brunswick0.03***
(0.01,0.05)
 Newfoundland and labrador1.82
(0.98,3.39)
 Nova Scotia1.06
(0.50,2.24)
 Prince Edward Island2.04*
(1.11,3.77)
 Quebec0.59
(0.30,1.17)
 Askatchewan0.63
(0.31,1.26)
Date of survey1
(1.00,1.00)

Note: OR: exponentiated coefficients; CI: confidence intervals.

*P < 0.05, **P < 0.01, ***P < 0.001.

Predictors of Increase in Substance Use Due to the Coronavirus Disease 2019 (COVID-19) Pandemic Among Youth and Young Adults Using at Least One Substance (n = 6,721). Note: OR: exponentiated coefficients; CI: confidence intervals. *P < 0.05, **P < 0.01, ***P < 0.001.

Discussion

In this survey, most youth and young adults aged 16–25 years old in Canada who used substances reported an increase in the use of one of more substances during the COVID-19 pandemic. The fact that Ontario had a stricter lockdown measures than British Columbia and Prince Edward Island during October and November 2020, when half of the study participants were recruited, may contribute to the higher likelihood of substance use among youth residing in the latter provinces. Use of any substance long-term is associated with health risks, and the dramatic increase in use may lead to tremendous health concerns without immediate action. This study did not have representative sampling frame; however, post-stratification weights were used to match the sample to the characteristics of the Canadian population. Additionally, we did not evaluate the magnitude of the increases or decreases in youth. Further research is needed to examine longitudinal changes in substance use among youth and young adults over time. Click here for additional data file. Supplemental material, sj-docx-1-cpa-10.1177_07067437211042132 for Perceived Impact of COVID on Smoking, Vaping, Alcohol and Cannabis Use Among Youth and Youth Adults in Canada by Michael Chaiton, Jolene Dubray, Anasua Kundu and Robert Schwartz in The Canadian Journal of Psychiatry
  4 in total

1.  Impacts of COVID-19 on Youth Mental Health, Substance Use, and Well-being: A Rapid Survey of Clinical and Community Samples: Répercussions de la COVID-19 sur la santé mentale, l'utilisation de substances et le bien-être des adolescents : un sondage rapide d'échantillons cliniques et communautaires.

Authors:  Lisa D Hawke; Skye Pamela Barbic; Aristotle Voineskos; Peter Szatmari; Kristin Cleverley; Em Hayes; Jacqueline Relihan; Mardi Daley; Darren Courtney; Amy Cheung; Karleigh Darnay; Joanna L Henderson
Journal:  Can J Psychiatry       Date:  2020-07-14       Impact factor: 4.356

2.  Retail Alcohol and Tobacco Sales During COVID-19.

Authors:  Brian P Lee; Jennifer L Dodge; Adam Leventhal; Norah A Terrault
Journal:  Ann Intern Med       Date:  2021-03-02       Impact factor: 25.391

3.  Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study.

Authors:  Sameer Imtiaz; Samantha Wells; Jürgen Rehm; Hayley A Hamilton; Yeshambel T Nigatu; Christine M Wickens; Damian Jankowicz; Tara Elton-Marshall
Journal:  J Addict Med       Date:  2020-12-14       Impact factor: 3.702

4.  What Does Adolescent Substance Use Look Like During the COVID-19 Pandemic? Examining Changes in Frequency, Social Contexts, and Pandemic-Related Predictors.

Authors:  Tara M Dumas; Wendy Ellis; Dana M Litt
Journal:  J Adolesc Health       Date:  2020-07-18       Impact factor: 5.012

  4 in total
  3 in total

1.  Investigating the early impacts of the COVID-19 pandemic on modifiable risk factors for cancer and chronic disease: a repeated cross-sectional study in Alberta, Canada.

Authors:  Geneviève Jessiman-Perreault; Alvin Li; Nicole Frenette; Lisa Allen Scott
Journal:  Can J Public Health       Date:  2022-09-01

2.  Examining the Impact of the COVID-19 Pandemic on youth Alcohol Consumption: longitudinal Changes From Pre-to Intra-pandemic Drinking in the COMPASS Study.

Authors:  Mahmood R Gohari; Thepikaa Varatharajan; James MacKillop; Scott T Leatherdale
Journal:  J Adolesc Health       Date:  2022-09-07       Impact factor: 7.830

3.  Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury ('EVALI').

Authors:  Katherine East; Jessica L Reid; Robin Burkhalter; Olivia A Wackowski; James F Thrasher; Harry Tattan-Birch; Christian Boudreau; Maansi Bansal-Travers; Alex C Liber; Ann McNeill; David Hammond
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.